Teleflex (TFX) to Release Earnings on Thursday

Teleflex (NYSE:TFX) is anticipated to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Teleflex to post earnings of $3.86 per share and revenue of $813.24 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Teleflex Stock Up 0.1 %

Shares of Teleflex stock opened at $177.78 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a 50-day moving average of $176.98 and a 200 day moving average of $206.74. The firm has a market cap of $8.26 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 1.73 and a beta of 1.16. Teleflex has a 1 year low of $165.62 and a 1 year high of $249.90.

Wall Street Analysts Forecast Growth

TFX has been the subject of several research reports. Royal Bank of Canada decreased their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Truist Financial reduced their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $246.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.